Document is current
Any future updates will be listed below
-
Authors
Rigby, William
Buckner, Jane H.
Louis Bridges, S. Jr
Nys, Marleen
Gao, Sheng
Polinsky, Martin
Ray, Neelanjana
Bykerk, Vivian http://orcid.org/0000-0002-1219-3845
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb (N/A)
- License Information
-
More Information
Article History
Received: 8 April 2021
Accepted: 14 August 2021
First Online: 18 September 2021
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and International Conference on Harmonization Good Clinical Practice. The protocol and patient’s informed consent received institutional review board/independent ethics committee approval prior to initiation of the study.
: Patient consent for publication was not required.
: WR has acted as a consultant for AbbVie, Bristol Myers Squibb, Genentech, Gilead, and Pfizer. JB was a paid consultant for Eli Lilly, is on the advisory board of GentiBio, and received grant/research support from Bristol Myers Squibb, Eli Lilly, Janssen, Novo Nordisk, and Pfizer. SLB has nothing to declare. MN, SG, MP, and NR are shareholders in and employees of Bristol Myers Squibb. VB received grant/research support (paid to institution) from Amgen, Bristol Myers Squibb, the Cedar Hill Foundation, and the NIH; consulting fees from Bristol Myers Squibb; and financial support from Amgen, Bristol Myers Squibb, Gilead, Pfizer, and UCB.
